AKT1 and breast carcinoma: In breast cancer cells, stimulation of ErbB receptors or the insulin-like growth factor-1 receptor augments P-Rex1 GEF activity towards Rac by switching on a phosphorylation/dephosphorylation cycle of P-Rex1 [4, 24].